Skip to content
Biotech Visionary Is Skeptical About AI’s Impact on Medical Innovation
Bloomberg
BusinessBloomberg··1 min read

Biotech Visionary Is Skeptical About AI’s Impact on Medical Innovation

The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human effort in the realm of scientific discovery, adding to a growing debate over its impact on medical research and innovation.

View original source — Bloomberg